key: cord-0997785-sv7mtzhu authors: Grech, Victor; Cuschieri, Sarah title: COVID-19: A global and continental overview of the second wave and its (relatively) attenuated case fatality ratio date: 2020-10-03 journal: Early Hum Dev DOI: 10.1016/j.earlhumdev.2020.105211 sha: 685350669f7cf602d0d379664d5065fde77d7a24 doc_id: 997785 cord_uid: sv7mtzhu Introduction COVID-19 is pandemic. International travel bans in March 2020 dampened viral spread and resulted in an overnight global economic crisis. As countries ease travel and social distancing restrictions, viral resurgences are expected. This study was carried out in order to delineate the development of a second wave of COVID-19 cases and deaths due to lockdown easements in June–July 2020. Methods Publically available data for daily new cases and deaths from December 2019 to September 2020 was obtained from “Our World In Data” website and analysed with Pearson correlation. Results At global level, both datasets exhibited three distinct time periods. Cases rose to mid-April, plateaued till mid-May then rose again. Almost all of the slopes in these three time periods were statistically significant. Deaths followed a similar three-part pattern, albeit more pronounced, with values lagging circa one week after new cases and a middle time period when numbers (of deaths) actually decreased, with all periods exhibiting significant slopes. At continent level, for new cases, Asia rose steadily, Europe is increasing again, the Americas and Africa are declining. Deaths follow a similar pattern. Oceania shows a bimodal pattern, with a first and second wave of cases shortly followed by deaths in a similar pattern. The monthly ratio of detected cases to deaths (case fatality ratio) initially rose to 0.08, then fell to 0.02. Conclusion The world is in its second wave of COVID-19, with fortunately reduced case fatality ratios. The world continues to struggle in the grip of the COVID-19 pandemic that was initially identified in Wuhan, China, in December 2019 [1] . This resulted in international travel bans in March 2020 in an attempt to dampen viral spread, a measure that affected over 90% of the world's population [2] . This, accompanied by social distancing measures, resulted in an overnight global crisis for both tourism and hospitality sectors, crucial pillars of national economies [3] . The measures were effective in dampening the pandemic, may have delayed many millions of infections and averted the deaths of millions more [4, 5] . COVID-19 is a beta coronavirus not an influenza virus but its transmission epidemiology is similar to influenza and it is therefore constructive to review the progression of historical influenza pandemics. These have followed wave patterns, with a peak usually succeeded by a second wave a few months later [6] . Virtually all countries commenced easement out of social distancing measures and travel bans in June-July 2020, hoping to step into a "new normal" that still includes public health prevention measures in an attempt to slowly restart national economies [3] . This naturally invoked the risk of viral resurgence [7] , a veritable balancing act between stimulating economies and morbidity/mortality from COVID-19 [2] . For COVID-19, it was speculated that as lockdowns were lifted, infections would rise again, followed by declines as lockdowns (in various degrees) are once more imposed, potentially leading to successive wave/s whose length/s and amplitude/s are determined by herd immunity and the stringency of applied lockdowns [8] . Resurgences are expected to further take tolls not only on pandemic morbidity and mortality but also on affected countries' economies [9] . This paper will outline the global and continental development of a second wave of COVID-19 cases relating to the easing of lockdowns in almost all countries in June -July 2020 and the short-term aftermath vis-à-vis death rates. Publically available data at global and at continental level for daily new cases and deaths from December 2019 to September 2020 was obtained from "Our World In Data" website [10] . Data is naturally only available for confirmed cases as it is estimated that there are many asymptomatic or mild cases that are undocumented and that some cases may simply never be recorded, even if death ensues, simply due to the absence of sufficient testing capacity (e.g. developing countries). Data was analysed with Pearson correlation in Excel using bespoke spreadsheets [11] . Graphs are also depicted using 14 day moving averages. In statistics, a moving average (rolling average or running average) calculates a series of averages of different subsets of the full data set. The first value of the moving average is obtained by taking the average of the initial set of datapoints (here 14 days) of the series. The subset is modified by shifting forward; excluding the first number of the series and including the next value. This calculation is used in time series data to smooth out short-term fluctuations and highlight longer-term trends/cycles. A p-value ≤ 0.05 was considered to be a statistically significant result. At global level, both datasets exhibited three distinct time periods. Daily new COVID-19 cases rose to mid-April, plateaued till mid-May then rose again (figure 1). Almost all of the slopes in these three time periods were statistically significant (table 1) . Deaths followed a similar threepart pattern, albeit more pronounced, with values lagging circa one week after new cases and a middle time period when numbers (of deaths) actually decreased, with all periods exhibiting significant slopes ( figure 2 and table 1 ). At continent level, for new cases, Asia rose steadily, Europe plateaued and is increasing again, the Americas and Africa are declining ( figure 3 ). Deaths are stabilising or falling everywhere except in Asia (figure 4). Due to smaller numbers, Oceania is plotted separately, and this shows a bimodal pattern, with a first and second wave of cases shortly followed by deaths in a similar pattern ( figure 5 ). The ratio of detected cases to deaths (case fatality ratio) initially rose to 0.08, then fell to 0.02 (table 2). As anticipated, once lockdowns and restrictions were eased, cases of COVID-19 rose rapidly worldwide. The world is clearly in the grip of a second wave of COVID-19, with no imminent vaccine in sight. However, the case fatality ratio has fallen, a puzzling but fortunate finding [12, 13] . Some pharmacological treatments may be modifying the natural history of the disease and these include remdesivir, dexamethasone and convalescent plasma, with improved outcomes [14] . Furthermore, healthcare workers have gained and shared their now voluminous experiences in treating affected patients [15] . However, while these advances seemed to have stemmed the tide of deaths in Europe and North America, with a stable mortality despite more cases, this is not the case in much of the rest of the world. The true toll of this pandemic may never quite be established as cases in developing countries may not be recorded [16] . Even in developed countries, for various reasons, the true toll may only be estimated by calculating excess deaths when compared to similar time periods in recent years [17] . Countries are desperate to restart economies and have opened up to travel and are also competing with a variety of incentives in order to lure visitors. However, public health measures must be maintained: social distancing, hygiene and the rigorous use of face masks in public areas: 'my mask protects you, your mask protects me' [18] . Countries may also be able to avoid viral resurgence or dampen it by releasing restrictions slowly, as per WHO criteria [19] : 4. Workplace preventive measures are established, including physical distancing, handwashing facilities and respiratory etiquette; 5. Importation risks can be managed; and 6. Communities have a voice and are aware, engaged and participating in the transition. It is vital for all countries to remain vigilant and act swiftly so as to instantly arrest/dampen COVID-19 case spikes. Health issues are particularly relevant as in the developed countries, it has been estimated that if Gross Domestic Product (GDP) were to drop by 6% or more, more years of life would be lost due to recession than would be gained through lives saved, as affluent countries would be able to spend less on healthcare, safety and the environment [20] . The resuscitation of economies must therefore literally constitute a "a risk balancing act -tourism competition using health leverage in the COVID-19 era" This is proving to be very difficult with countries (such as the UK and Malta and indeed all countries without draconian measures) experiencing high infection rates as restrictions are eased [21, 22] . The only solution will be an effective vaccine becomes available, [23] and even then, if vaccine uptake is poor [24] , or the vaccine only partially effective (as is for example the influenza vaccine) [25] , restrictions of sorts may still need to be imposed for years to come until a measure of herd immunity from vaccination or natural infection is attained. Clinical features of patients infected with 2019 novel coronavirus in Wuhan A risk balancing act -tourism competition using health leverage in the COVID-19 era The Extent of COVID-19 Pandemic Socio-Economic Impact on Global Poverty. A Global Integrative Multidisciplinary Review The effect of large-scale anti-contagion policies on the COVID-19 pandemic Estimating the effects of nonpharmaceutical interventions on COVID-19 in Europe Death from 1918 pandemic influenza during the First World War: a perspective from personal and anecdotal evidence Covid-19: Risk of second wave is very real, say researchers Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand Record economic slumps hit Europe in face of resurgent virus Coronavirus Source Data -Our World in Data WASP (Write a Scientific Paper) using Excel -13: Correlation and Regression Flattening-the-curve associated with reduced COVID-19 case fatality rates-an ecological analysis of 65 countries The many estimates of the COVID-19 case fatality rate Drug treatments for covid-19: living systematic review and network meta-analysis Handbook of COVID-19 Prevention and Treatment Bearing the brunt of covid-19: older people in low and middle income countries Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States A modelling framework to assess the likely effectiveness of facemasks in combination with 'lock-down' in managing the COVID-19 pandemic World Health Organization, Strengthening and adjusting public health measures throughout the COVID-19 transition phases. Policy considerations for the WHO European Region Nanotechnology perceptions Covid-19: Experts divide into two camps of action-shielding versus blanket policies Mass Events Trigger Malta's Second Peak After Initial Successful Pandemic Suppression Developing a vaccine for covid-19 Restoring confidence in vaccines in the COVID-19 era Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season The authors have no conflict of interest to declare.